F2G Alternatives & Competitors
12 companies similar to F2G — The rare fungal disease company
Companies similar to F2G
Solid Biosciences
#TogetherWeAreSolid
Spero Therapeutics
Clinical-stage biotech company focused on rare diseases and diseases with high unmet need
Quercis Pharma
For a Healthier World
Emmaus Life Sciences, Inc
Improving the lives of people with rare disease.
Rival Readout
Competing with F2G? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Neurolixis
New treatments for central nervous system disorders
ContraFect Corp
...focused on discovering & developing differentiated biologic therapies for life-threaten...
AusperBio
Transforming Patient Lives For a Better Tomorrow
Lumos Pharma
Transforming Lives with Rare Focus
Eiger BioPharmaceuticals
Developing innovative therapies to treat and cure rare metabolic diseases
Alkeus Pharmaceuticals, Inc.
Transformation in Sight
Versantis
Multiorgan support for rare pediatric and acute liver diseases
About F2G
F2G, known as "The rare fungal disease company," is a pioneering clinical-stage biopharmaceutical firm headquartered in the United Kingdom. Founded in 1998, the company is at the forefront of developing therapies for life-threatening invasive fungal infections. Central to F2G's innovation is the creation of a novel cla...
Development of Antifungal Therapies, Research and Development in Fungal Infections, Early Access to Investigational Therapies
Patients with Rare Fungal Infections, Healthcare Providers, Medical Researchers
Biopharmaceutical, Clinical-stage, Fungal Disease, Orotomides, Antifungal Agents, Invasive Fungal Infections, Dihydroorotate Dehydrogenase, Pyrimidine Biosynthesis, Olorofim, Fungicidal Activity, Rare Mould Infections, Phase 3 Trial, Orphan Drug Status, Breakthrough Therapy Designation, Proprietary Genomics Technology
B2B, B2D
Product Sales, Licensing, Service Fee
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around F2G: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at F2G on 11 Mar 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.